Print

Argos Therapeutics, Inc. (ARGS) To Present At Two Upcoming Healthcare Conferences  
6/11/2014 6:36:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DURHAM, N.C., June 11, 2014 (GLOBE NEWSWIRE) -- Argos Therapeutics, Inc. (Nasdaq:ARGS), a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, today announced that Jeff Abbey, president and chief executive officer, will be presenting at the 2014 Wells Fargo Healthcare Conference on June 17, 2014, at 4:40 p.m. Eastern Time at The InterContinental Hotel in Boston, MA. Mr. Abbey will also participate in a fireside chat at the JMP Securities 2014 Healthcare Conference on June 25, 2014 at 2:30 p.m. Eastern Time at The Westin New York Grand Central Hotel, in New York, NY.

Help employers find you! Check out all the jobs and post your resume.

//-->